Jeremy Cook
Foot & Ankle Surgery · Cambridge, MANPI 1023221082
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,780 of the $4,390 with a category attached, or 86.1%. 8 manufacturers reported payments, led by Hologic Inc at 47.8% of the total. Reporting peaked in 2021 at $1,724 and has fallen 90.4% since, to $166 in 2025.
Across 20 payments — averaging $219.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Inc$2K
- Paratek Pharmaceuticals, Inc.$2K
- Stryker$404
- Innovation Technologies Inc$80
- Zimmer Biomet$44
- Smith+Nephew$41
- plus $40 from 2 others
Across 4 payments — averaging $26,574 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Smith+Nephew$106K
What the payments were for
- Consulting fees$3,78086%
- Food & beverage$61014%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Inc | 2 | $2,100 |
| Paratek Pharmaceuticals, Inc. | 1 | $1,680 |
| Stryker(2 entities) | 11 | $404 |
| Innovation Technologies Inc | 1 | $80 |
| Zimmer Biomet | 1 | $44 |
| Smith+Nephew | 2 | $41 |
| Orthofix Medical, Inc. | 1 | $23 |
| Bioventus LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NUZYRA$1,680
- ORTHOLOC 3DI$166
How this compares
$4,390 in reported general payments places this provider in the 70th percentile of 122 foot & ankle surgery providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 21 | $457 |
| Meloxicam | 18 | $72 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Cambridge
- Harry SchneiderCambridge$174K
- Philip BasileCambridge$90K
- Joshua ManningCambridge$5K
- Emily CookCambridge$2K
- Jeffrey NgCambridge$2K
- Craig LareauSpringfield$115K
- David SipalaBrighton$94K
- Michael SgangaNatick$90K
- Joseph FleckNorth Chelmsford$35K
- Michael SkoniecznyPlymouth$33K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.